Research use only

In stock · depth page

SS-31 — recent literature (RUO)

SS-31 / elamipretide literature, 2023–2026

SS-31 10 mg · literature note

For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide. This research material is not a licensed elamipretide product.

Clinical-development discussion in the literature stays context. It does not make this catalog vial a licensed elamipretide product.

How to read recent hits

Tung et al. (2025) reviews elamipretide structure and mechanism. Zheng et al. (2025) reports SS-31 mitochondrial targeting and ferroptosis readouts in hypoxia/reoxygenation cardiomyocytes. Zhao et al. (2004) and Birk et al. (2014) remain the mitochondria-targeted and cardiolipin anchors.

Review and cell-model papers stay literature context for research-use-only procurement.

Identity

Form

Lyophilized powder, sealed vial

Strength

10 mg lyophilized vial

Purity

≥99% HPLC

CAS

  • Elamipretide / SS-31: 736992-21-5

PubMed

Selected literature

  • PMID 15178689 (2004) Zhao et al., Journal of Biological Chemistry — mitochondria-targeted peptide antioxidants
  • PMID 24134698 (2014) Birk, Szeto et al., British Journal of Pharmacology — cardiolipin and cytochrome c targeting

Recent literature (2023–2026)

  • PMID 39940712 (2025) Tung et al., International Journal of Molecular Sciences — elamipretide structure and mechanism (review)
  • PMID 39848110 (2025) Zheng et al., Biomedicine & Pharmacotherapy — SS-31 mitochondrial targeting and ferroptosis readouts in hypoxia/reoxygenation cardiomyocytes

Literature is scientific context only. A paper does not make a research vial into a licensed medicine.

Bench reconstitution

Dissolve the lyophilized SS-31 cake in bacteriostatic water to the mg/mL the protocol specifies. Run solvent down the glass wall. Swirl gently until the cake is gone. Do not vortex or shake. Record concentration, solvent lot, and time. This is a reconstitution volume, not a clinical dose.

Diluent page: bacteriostatic water.

Storage

Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.

Certificate of analysis

Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.

Lab FAQ

Do review or cardiomyocyte models authorize human-use claims?

No. Papers remain literature context. Write request@pharmapeptidesrx.com to add SS-31 to a research request. This page does not publish prices or banking details. Invoices go out from request@ only.

In this library

In stock · list price

Request from the catalog

Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.